KTTA vs REGN: Which Stock is Better?

Side-by-side comparison of Pasithea Therapeutics Corp and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

KTTA

Pasithea Therapeutics Corp

$0.74

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricKTTAREGNWinner
Market Cap$18.52M$79.35BREGN
P/E RatioN/A18.08REGN
EPS (TTM)$N/A$41.51REGN
Revenue Growth15.0%0.0%KTTA
Gross Margin-0.5%44.6%REGN

Analyze KTTA

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KTTA or REGN a better investment?

Comparing KTTA and REGN: Pasithea Therapeutics Corp has a market cap of $18.52M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KTTA and REGN?

KTTA (Pasithea Therapeutics Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KTTA or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: KTTA or REGN?

KTTA has higher revenue growth at 15.0% vs 0.0% for REGN.

Which company is more profitable: KTTA or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -0.5% for KTTA.

Which is the larger company: KTTA or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $18.52M for KTTA.

Should I buy KTTA or REGN in 2026?

Both KTTA and REGN have investment merit. KTTA trades at $0.74 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KTTA and REGN stock?

Key differences: Market Cap ($18.52M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (15.0% vs 0.0%), Gross Margin (-0.5% vs 44.6%).

Popular Stock Comparisons